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BACKGROUND: The Centers for Medicare & Medicaid
Services publicly reports risk-standardized mortality
rates (RSMRs) within 30-days of admission and, in
2013, risk-standardized unplanned readmission rates
(RSRRs) within 30-days of discharge for patients hospi-
talized with acute myocardial infarction (AMI), heart
failure (HF), and pneumonia. Current publicly reported
data do not focus on variation in national results or
annual changes.
OBJECTIVE: Describe U.S. hospital performance on
AMI, HF, and pneumonia mortality and updated read-
mission measures to provide perspective on national
performance variation.
DESIGN: To identify recent changes and variation in
national hospital-level mortality and readmission for
AMI, HF, and pneumonia, we performed cross-sectional
panel analyses of national hospital performance on
publicly reported measures.
PARTICIPANTS: Fee-for-service Medicare and Vet-
erans Health Administration beneficiaries, 65 years
or older, hospitalized with principal discharge diag-
noses of AMI, HF, or pneumonia between July 2009
and June 2012. RSMRs/RSRRs were calculated
using hierarchical logistic models risk-adjusted for
age, sex, comorbidities, and patients’ clustering
among hospitals.
RESULTS: Median (range) RSMRs for AMI, HF, and
pneumonia were 15.1% (9.4–21.0%), 11.3% (6.4–
17.9%), and 11.4% (6.5–24.5%), respectively. Median
(range) RSRRs for AMI, HF, and pneumonia were 18.2%
(14.4–24.3%), 22.9% (17.1–30.7%), and 17.5% (13.6–
24.0%), respectively. Median RSMRs declined for AMI
(15.5% in 2009–2010, 15.4% in 2010–2011, 14.7% in
2011–2012) and remained similar for HF (11.5% in
2009–2010, 11.9% in 2010–2011, 11.7% in 2011–2012)
and pneumonia (11.8% in 2009–2010, 11.9% in 2010–
2011, 11.6% in 2011–2012). Median hospital-level
RSRRs declined: AMI (18.5% in 2009–2010, 18.5% in
2010–2011, 17.7% in 2011–2012), HF (23.3% in 2009–
2010, 23.1% in 2010–2011, 22.5% in 2011–2012), and
pneumonia (17.7% in 2009–2010, 17.6% in 2010–
2011, 17.3% in 2011–2012).
CONCLUSIONS: We report the first national unplanned
readmission results demonstrating declining rates for
all three conditions between 2009–2012. Simulta-
neously, AMI mortality continued to decline, pneumo-
nia mortality was stable, and HF mortality experienced
a small increase.
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INTRODUCTION
The Centers for Medicare & Medicaid Services (CMS)
began reporting hospital-specific 30-day risk-standardized
mortality rates (RSMRs) for patients hospitalized with acute
myocardial infarction (AMI) and heart failure (HF) in June
2007, and for patients hospitalized with pneumonia in 2008
through the Hospital Inpatient Quality Reporting (IQR)
Program (formerly known as the Reporting Hospital
Quality Data for Annual Payment Update program). In
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2009, CMS also began reporting hospital-specific 30-day
risk-standardized readmission rates (RSRRs) for all three
conditions.1–14
Patients and other stakeholders can compare individ-
ual hospitals’ performance on these six quality measures
on CMS’s Hospital Compare website.15 However, this
resource does not provide information on the distribu-
tion of hospital performance for the nation as a whole,
nor does it examine changes within the 3-year publicly
reported measurement period. Although similar informa-
tion was published in 2010,16,17 these measures are
updated with new data each year and there has been no
peer-reviewed summary since CMS began publicly
reporting readmission rates. Furthermore, in 2011,
CMS expanded national reporting to include Veterans
Health Administration (VA) hospitals, and in 2013,
updated the readmission measures to include only
unplanned readmissions as measure outcomes.
We aim to describe the performance of U.S. hospitals on
mortality and readmission measures following hospitaliza-
tions for AMI, HF, and pneumonia. Specifically, we
summarize the national distribution of variation in hospital
performance on the publicly reported outcomes measures
based on the most current data (July 2009 to June 2012) and




The cohort for the six measures consists of hospitaliza-
tions for all Medicare fee-for-service (FFS) and VA
beneficiaries aged 65 years and older, discharged from
non-federal or VA acute care hospitals and having a
principal discharge diagnosis of AMI, HF, or pneumo-
nia. Medicare FFS beneficiaries are included if they
have been enrolled in Medicare for the 12 months
before and including the date of the index admission to
ensure a full year of data for risk adjustment. The index
hospitalization is the admission being measured for the
outcome and identified based on patients’ principal
discharge diagnosis. Discharges included in the publicly
reported measures in 2013 occurred during July 2009
through June 2012. Additional details on measure
methodology are provided in the online Appendix and
published elsewhere.1–14 For patients with multiple
hospitalizations for the same condition during a single
year, the mortality measures include one randomly
selected hospitalization per year per eligible patient per
condition. For readmission measures, patients must be
discharged alive for inclusion and may have multiple
index admissions per year, but only admissions after
30 days of discharge from an index admission are
eligible to be included as additional index admissions.
Data Sources
The data sources are CMS administrative (claims and
enrollment) data and VA administrative data. Index
hospitalizations and readmissions are identified from
inpatient claims. Dates of death were ascertained from
the CMS enrollment database and VA records. To
identify patient risk factors, the measures use inpatient
and outpatient claims from the year prior to the index
admission and secondary diagnosis codes from the index
admission. The online Appendix contains additional
details on measure methodology.
Outcomes
The mortality measures assess death from any cause, within
30 days of admission for the index hospitalization. The
mortality outcome is attributed to the initial admitting
hospital, regardless of subsequent transfers.
The readmission measures assess unplanned re-hospital-
ization to any acute care facility for any cause within
30 days of discharge from the index hospitalization.
Readmissions to observation status or non-acute units such
as rehabilitation are not included. Readmission is attributed
to the hospital that ultimately discharges a patient to a non-
acute care setting (e.g. home, skilled nursing facility).
Planned readmissions, such as hospitalizations reflecting
readmissions for elective chemotherapy or scheduled
procedures, are not considered outcome events in these
measures and are defined using a publicly vetted approach
that is delineated in the supplemental online Appendix.
Risk-Standardized Rates
Details of the risk models used are provided in the online
Appendix. The measures calculate hospital-level risk-
standardized mortality or readmission rates using the
hierarchical logistic regression model currently used in the
publicly reported outcome measures to account for cluster-
ing of patients within hospitals while risk-adjusting for
differences in patient case-mix. Each model includes age,
sex, selected clinical covariates, and a hospital-specific
random intercept using 3-year rolling combined or separate
annual data. Comorbidities from the index admission that
could represent complications of care are not included in the
risk adjustment unless they are also present in claims within
12 months prior to admission to avoid attenuating the
measures’ ability to characterize hospital care quality. The
hospital-level RSMRs and RSRRs are calculated as ratios of
the number of “predicted” to the number of “expected”
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outcome events for each hospital, which are then
multiplied by the national unadjusted outcome rate. For
each hospital, the ratio numerator is the number of
outcome events predicted by the hospital’s performance
with its observed case-mix (using a hospital-specific
estimated intercept term), and the denominator is the
number of expected deaths or readmissions based on the
nation’s performance using the hospital’s observed case-
mix. We used 5,000 bootstrap iterations to estimate 95%
confidence intervals and variance for RSRRs/RSMRs for
public reporting. Further details are provided else-
where.9–13
Analyses
To describe national hospital variation in publicly reported
RSMRs/RSRRs, we evaluated their corresponding descrip-
tive statistics, such as mean, standard deviation, median,
and ranges. Hospitals were further characterized as “better”
(“worse”) than the national rate if their risk-standardized
rate was lower (higher) than the national rate and 95%
confidence intervals did not include the national rate; if the
hospital’s 95% confidence intervals included the national
rate, the hospital was characterized as “no different than”
the national rate.
To report annual changes in outcomes, a 1-year (July 1
through June 30) RSMR or RSRR was calculated for each
hospital, condition, and measure for July 2009 through
June 2012. For patients with multiple eligible admissions
within a 1-year period, we selected a single index
admission for inclusion in the mortality analyses. We
calculated the median hospital rate and inter-quartile range
at each time point for each measure. We used a generalized
estimating equation (GEE) model to test whether the mean
annual RSMR/RSRR changed significantly over the three
year reporting period. We used annual hospital RSMRs/
RSRRs as dependent variables and the three 12-month time
periods as independent variables, and accounted for the
correlation among the same hospitals over time. We also
conducted pairwise comparisons of mean RSRRs or
RSMRs between different time periods.
We calculated the number of hospitals changing perfor-
mance categories and absolute differences in hospital-level
risk-standardized rates between the 2012 (prior year) and
2013 (current) public reporting periods. We report these
changes as “improved” (“worse than” to “no different than”
national rate, “no different than” to “better than” national
rate, or “worse than” to “better than” national rate), “no
change”, or “worsened” (“no different than” to “worse
than” national rate, “better than” to “no different than”
national rate, or “better than” to “worse than” national rate).
All analyses were done with SAS version 9.2 (SAS
Institute Inc., Cary, NC). We created figures with R (version




The measures include data from more than 4,500 hospitals.
Over the 3-year period, we included 511,404 admissions in
the AMI mortality measure cohort, 1,042,203 for HF
mortality, and 1,037,583 for pneumonia mortality (Table 1).
The case volume for the AMI, HF mortality, and pneumonia
measures declined by 4–8% (7,094, 28,007 and 14,247
patients, respectively) between the first and last year of the
2013 reporting period. For the readmission measures, there
were 513,331 AMI, 1,262,826 HF, and 1,089,758 pneumo-
nia discharges over the three-year period and even larger
declines (9–15%) between the first and last year of the
reporting period (Table 1).
Variation in Hospital-Specific Risk-
Standardized Rates (Table 2 and Figs. 1–2)
For the mortality measures, there was an absolute
difference of 4.4%, 5.2%, and 6.0% between the median
RSMRs for the 5th and 95th percentiles of hospitals for
AMI, HF, and pneumonia, respectively. For the read-
mission measures, the absolute difference between the
5th and 95th percentiles of hospital RSRRs was 3.5%,
6.1%, and 4.8% for AMI, HF, and pneumonia, respec-
tively.
Changes in Hospital Performance
(Tables 2 and 3)
The annual hospital-level 30-day RSMRs revealed
a decline of 0.8% in the median (Table 2) and mean
rates for AMI (data not shown, p<0.001 for trend).
During the same period, the median and mean annual
hospital-level 30-day RSMR for HF increased by
an absolute 0.2% (p<0.001 for trend between 2009–
2010 and 2011–2012, first and last years of current
reporting period) and decreased for pneumonia by an
absolute 0.2% (p<0.001 for trend between 2009–2010
and 2011–2012, the first and last years of current
reporting period).
There has been a statistically and clinically significant
decrease in the annual mean RSRRs for all three measures
(absolute decreases of 0.8% for AMI, 0.8% for HF and
0.4% for pneumonia, all p<0.001, Table 2) between the first
and last year of the 2013 reporting period.
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Between the 2012 reporting period and the 2013 reporting
period, no hospital moved from better to worse than the
national rate or vice versa (Table 3). Across the six measures,
93–97% of hospitals remained in the same performance
category; between 1.6% (AMI readmission) and 4.0%
(pneumonia mortality) of hospitals improved categories; and
between 1.0% (pneumonia readmission) to 3.9% (pneumonia
mortality) of hospitals moved to a lower performance
category. Median RSMRs for hospitals performing “better
than the national rate” were 7.7%, 6.4%, and 7.0% lower for
AMI, HF, and pneumonia, respectively, than median RSMRs
for those hospitals performing “worse than the national rate.”
Median RSRRs were 6.4%, 7.6%, and 6.7% lower for “better
than national rate” compared to “worse than national rate”
hospitals for the AMI, HF, and pneumonia readmission
measures, respectively.
Table 1. Study Sample Characteristics and Crude Outcome Rates
Mortality Readmission
Characteristics AMI HF Pneumonia AMI HF Pneumonia
No. of Cases
July 2009 – June 2012 (full reporting period) 511,404 1,042,203 1,037,583 513,331 1,262,826 1,089,758
July 2009 – June 2010 173,576 359,589 347,585 177,031 447,351 371,002
July 2010 – June 2011 171,346 351,032 356,660 176,195 434,083 382,700
July 2011 – June 2012 166,482 331,582 333,338 160,105 381,392 336,056
No. of Hospitals 4,564 4,777 4,817 4,464 4,786 4,833
Patient Age, years
Median 79 82 81 79 81 80
25th percentile 72 75 74 72 74 74
75th percentile 86 87 87 85 87 86
Non-white, % 12.4 15.8 11.7 12.3 16.7 11.7
Eligible Hospital Cases*
Median 40 117 150 30 137 158
25th percentile 10 42 68 7 48 71
75th percentile 156 308 297 148 370 310
Crude National Rates for 3-Year Combined Data Used in Public Reporting, %
July 2009 – June 2012 (full reporting period) 15.2 11.7 11.9 18.3 23.0 17.6
Annual Crude National Rates, %
July 2009 – June 2010 15.5 11.5 11.9 18.6 23.4 17.7
July 2010 – June 2011 15.4 11.9 12.0 18.5 23.2 17.7
July 2011 – June 2012 14.8 11.7 11.7 17.7 22.5 17.3
*Eligible Hospital Cases represent the number of index hospitalizations per hospital meeting criteria for inclusion in the measure cohort within the
3-year measurement period; for example, the median number of admissions per hospital included in the final Acute Myocardial Infarction (AMI)
measure cohort was 40 hospitalizations
Table 2. Risk-Standardized Outcome Rates Following Hospitalizations for AMI, HF, and Pneumonia
Mortality Readmission
Outcome AMI HF Pneumonia AMI HF Pneumonia
Risk-Standardized Rates for 3-Year Combined Data Used in Public Reporting, %











Minimum 9.4 6.4 6.5 14.4 17.1 13.6
1st percentile 11.5 7.8 7.8 15.5 18.4 14.6
5th percentile 12.6 8.8 8.8 16.5 20.0 15.4
10th percentile 13.3 9.4 9.4 17.1 20.7 15.8
25th percentile 14.3 10.3 10.3 17.8 21.8 16.6
Median 15.1 11.3 11.4 18.2 22.9 17.5
75th percentile 15.8 12.3 12.6 18.7 24.2 18.4
90th percentile 16.5 13.4 13.9 19.5 25.3 19.5
95th percentile 17.0 14.0 14.8 20.0 26.1 20.2
99th percentile 18.2 15.4 16.4 21.1 27.9 21.6
Maximum 21.0 17.9 24.5 24.3 30.7 24.0
Annual Risk-Standardized Rates, %
Median Annual Hospital-Level RSMRs/RSRRs, %
July 2009 – June 2010 15.5 11.5 11.8 18.5 23.3 17.7
July 2010 – June 2011 15.4 11.9 11.9 18.5 23.1 17.6
July 2011 – June 2012 14.7 11.7 11.6 17.7 22.5 17.3
RSMRs/RSRRs are weighted by inverse of variance of RSRR/RSMR calculated from bootstrapping; RSMR risk-standardized mortality ratio; RSRR
risk-standardized readmission ratio
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DISCUSSION
Between July 2009 and June 2012, the current 3-year
measurement period for CMS’s public reporting of hospital
performance, our results demonstrate improvement in all
annual risk-standardized outcome rates for patients admitted
with AMI, HF, and pneumonia, except an increase of 0.2%
absolute percentage points in HF mortality. Despite this
improvement, in half of U.S. hospitals, one in seven
patients admitted for AMI will die within 30 days of
admission and one in four patients admitted with HF will be
readmitted with an unplanned readmission within 30 days
of discharge. Given the complexity of improving outcomes,
improvement in national rates is likely to be slow, but these
results allow an assessment of the trajectory of outcomes
within the 3 years included in current publicly-reported
results, showing that mortality following admission for
AMI continues to decline and unplanned readmission rates
for all three conditions indicate early signs of improvement.
However, HF mortality rose slightly over the reporting
period and pneumonia mortality did not demonstrate the
marked declines shown prior to 2005.19 These results reflect
outcomes after the start of public reporting and inclusion of
these measures in CMS’s pay-for-performance programs.20
In addition, the readmission rates now focus solely on
unplanned readmissions.
The measures continue to demonstrate wide perfor-
mance variation, with outcome rates for high performing
hospitals (10th percentile) at least three absolute per-
centage points lower than those for poor performing
hospitals (90th percentile) for five of six measures; the
AMI readmission measure demonstrates 2.4 absolute
percentage points between top and bottom deciles.
Documentation of this variation provides evidence of
continued room for improvement in care quality. The
publicly reported measures are designed to benchmark
an individual hospital against how an average hospital
performs when caring for a similar case-mix. The goal
of public reporting is not to reduce mortality or
readmission to zero, but rather to bring as many
hospitals as possible to the performance standards set
by the nation’s highest performing hospitals.
Although cross-sectional and including only the 3-year
current measurement period, these data are the first
indication that measure-specific readmission rates are
declining and support evidence published by Gerhardt, et.
al in 2013 that all-condition readmission rates are declin-
ing.21 Unlike that study as well as previous hospital-level
results reported on CMS’s Hospital Compare, our findings
indicate declining rates of unplanned readmissions after
hospitalization for AMI, HF, and pneumonia. These are the
first data to exclude planned readmissions from the
measures’ outcome and therefore it is inappropriate to
compare them directly to prior publicly reported results.
However, by excluding planned readmissions, such as
elective surgeries or planned chemotherapy, these results
better assess hospital care quality. Using a uniform
definition of unplanned readmission, median annual RSRRs
for AMI and HF decreased by nearly a full (absolute)
percentage point within the last 3 years of available data,
compared to year-to-year changes in annual median
RSRRs≤0.3 absolute percentage points between 2007 and
2010.22,23 While some year-to-year variation in rates cannot
be excluded, given the magnitude of recent changes
compared to recent historic data, these improvements are
unlikely to be random variation. If all hospitals with RSRRs
in excess of the median value had improved to the median
hospital RSRR, 5,072 AMI, 11,839 HF, and 14,494
A density plot shows the estimate of an unobservable underlying
probability density function. In the figure above, the horizontal
axis displays the outcome rate (RSMR) and the vertical axis shows
the density of hospitals.
Figure 1. Density plot of the distributions of hospital-level risk-
standardized mortality rates (RSMRs) following admission for
acute myocardial infarction (AMI), heart failure (HF) and
pneumonia, for the period 1 July 2009 through 30 June 2012.
A density plot shows the estimate of an unobservable underlying
probability density function. In the figure above, the horizontal
axis displays the outcome rate (RSRR) and the vertical axis shows
the density of hospitals.
Figure 2. Density plot of the distributions of hospital-level risk-
standardized readmission rates (RSRRs) following admission for
acute myocardial infarction (AMI), heart failure (HF) and
pneumonia, for the period 1 July 2009 through 30 June 2012.
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pneumonia unplanned readmissions would have been
averted during the 2013 public reporting period.
One concern expressed by critics of examining hospital
readmissions as a measure of hospital quality is that focus
on readmissions will divert attention from other important
quality improvement efforts and/or result in unintended
consequences.24 The most serious concern is that efforts to
reduce readmissions may lead hospitals to avoid re-
hospitalizing patients who need more intensive care, thus
leading to increased mortality rates in the post-discharge
period. With the exception of HF, which demonstrated a
0.2% absolute percentage point increase in median hospital
RSMRs between the first and last year of the current 3-year
reporting period, AMI and pneumonia mortality rates fell or
were stable simultaneous to declining readmission rates.
While this does not exclude a relationship between hospital
performance on mortality and readmission measures, this
finding is reassuring and supports earlier data that good
performance on readmission measures does not necessarily
occur at the expense of performance on the mortality
measures or vice versa.25 Gorodeski et al. demonstrated
that, at higher readmission rates, lower HF mortality was
associated with higher readmission; however, this relation-
ship did not exist for hospitals with the lowest readmission
rates, where mortality performance remained flat,26 and the
study did not examine outcomes for other conditions that
have been studied previously and found to have little
correlation.25 There is evidence that patients admitted now
are sicker, as each measure shows small increases in the
frequency of several risk covariates, such as cardiorespira-
tory failure and shock, over the measurement period (online
Appendix), supporting that the patient case mix may be
increasing in severity overtime. Despite this, only HF
mortality showed an overall increase in mortality, and in
fact, there was a decrease in HF mortality between the
second and third years of the reporting period. These data
merit further consideration, but reinforce the benefit of
measuring and reducing both mortality and readmission
rates simultaneously to prevent unintended consequences of
measurement and reporting. Further, these measures
supplement data captured by existing publicly reported
process measures that examine and incentivize guide-
line-concordant care, but often correlate poorly with
actual patient outcomes.27
There are several limitations to consider in interpreting
these results. First, administrative claims carry less face
validity for adequate case-mix adjustment compared to
clinical data. The risk models used in these measures have
been validated against and demonstrate similar performance
assessments to models based on medical record data.9–13
Second, reported rates only reflect the experience of
Medicare FFS and VA patients ages ≥ 65 and are not
necessarily generalizable to other populations. Third,
Medicare and VA data are combined prior to fitting the
models, allowing between hospital means and variances to
be different for the two systems. We did not explore
whether VA hospitals represented a disproportionate num-
ber of improving hospitals; however, VA hospitals contrib-
ute less than 3% of measured patients and therefore the
rates are largely driven by outcomes for index admissions to
non-federal hospitals. Fourth, although we have used a
robust risk-adjustment approach endorsed by statistical
experts,28 there may be other sources of variation contrib-
uting to the differences among hospital RSMRs and
RSRRs, including differences in coding practices that could
impact either risk adjustment or cohort definitions. This has
been identified as a concern for the pneumonia measures,
with recent evidence suggesting that more seriously ill
Table 3. Number of Hospitals With a Change in Performance Categorization (Current Reporting Period 1 July 2009 to 30 June 2012
Compared to Prior Year Period 1 July 2008 to 30 June 2011)
Mortality Readmission













Worse Than to No Different Than National Rate 17 54 95 28 63 53
No Different Than to Better Than National Rate 32 62 76 9 56 24
Worse Than to Better Than National Rate 0 0 0 0 0 0
No. with No Change
Worse Than National Rate 6 63 121 13 97 68
No Different Than National Rate 2,448 3,482 3,737 2187 3,652 4,092
Better Than National Rate 45 116 124 14 64 13
No. Worsened
No Different Than to Worse Than National Rate 13 73 99 16 59 24
Better Than to No Different Than National Rate 26 79 61 10 30 20
Better Than to Worse Than National Rate 0 0 0 0 0 0
Excludes hospitals with fewer than 25 cases during the reporting period as well as critical access hospitals and other hospitals not participating in
the Hospital Inpatient Quality Reporting program who requested that CMS suppress their results: AMIAcute Myocardial Infarction; HFHeart
Failure; Hospitals were characterized as “better” (“worse”) than the national rate if their risk-standardized rate was lower (higher) than the
national rate and 95% confidence intervals did not include the national rate; if the hospital’s 95% confidence intervals included the national rate,
the hospital was characterized as “no different than” the national rate
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pneumonia patients may be coded with respiratory failure or
sepsis and thus may not be included in measurement.29
Further, the measures do not adjust for code status or do not
resuscitate orders, as these are inconsistently applied by
clinicians and not captured in claims. However, the
mortality measures exclude patients enrolled in hospice at
any time during the 12-months prior to admission or who
enrolled in hospice on the first day of admission, as the
goals of care for such patients likely differ from patients not
participating in hospice. These measures have been previ-
ously validated using medical record-based models, mini-
mizing the likelihood that coding differences are the main
source of variation for all measures. Variation in the
propensity to admit patients or in care intensity may also
contribute to performance differences.
Examination of 2009–2012 data reveals variation in the
quality of care provided to patients with AMI, HF, and
pneumonia. Our study summarizes unplanned readmission
rates nationally and signals potential early declines in
readmission rates. The 2013 publicly reported measures
update suggests payment incentive programs may be
influencing hospital readmission performance without a
concomitant increase in mortality, at least for AMI and
pneumonia patients, and supports the need for simulta-
neously measuring mortality and readmission to encourage
better quality across all aspects of care and monitor for
unintended consequences.
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